
Sigma Nutrition Radio
by Danny Lennon
Is this your podcast?On the show
From 22 epsHost
Recent guests
Recent episodes
#623: Testosterone Testing: What Do the Results Mean? When Does TRT Help? – Austin Baraki, MD
Oct 13, 2026
1h 08m 19s
#622: Body Composition Testing: Methods & Interpretation – Prof. Grant Tinsley
Oct 6, 2026
1h 04m 02s
#621: Hedonic Overeating, Food Wanting and Impact of Perception – Prof. Graham Finlayson
Sep 22, 2026
42m 39s
#620: BPC-157 and Peptide Medications: What Do We Know? – Jordan Feigenbaum, MD
Sep 15, 2026
57m 32s
#619: How Much Fish Should a Healthy Diet Contain?
Sep 8, 2026
1h 03m 22s
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Based on 1 signal.
Built from
By chart position
- 🇺🇸United States · NutritionHOME#5159K to 310K
- 🇮🇱IL · Nutrition#214K to 75K
- 🇬🇧United Kingdom · Nutrition#2611K to 56K
- 🇿🇦ZA · Nutrition#66.0K to 32K
- 🇮🇳India · Nutrition#414.0K to 21K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
124K to 657K🎙 Weekly cadence·641 episodes·Last published 6d ago - Monthly Reach
Unique listeners across all episodes (30 days)
248K to 1.3M🇺🇸47%🇮🇱11%🇬🇧9%+18 more - Active Followers
Loyal subscribers who consistently listen
137K to 722K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 10/13/26 | #623: Testosterone Testing: What Do the Results Mean? When Does TRT Help? – Austin Baraki, MD | Men commonly feel that if their testosteone isn't "optimized" and high, they are missing out on greater health in a variety of ways. But what can a testosterone result actually tell us? How can results be interpreted with appropriate nuance that is needed? How low is low enough to be problematic? In situations where a test flags testosterone as low, there is a belief this means automatically starting testosterone replacement therapy. While TRT can be an excellent intervention in appropriate cases, when is it actually likely to benefit someone, and when is it not? For many people the decision seems straightforward: get a blood test, see whether testosterone is a little low, and start TRT. However, this simplistic thinking is full of potential issues that are important to understand. Dr. Austin Baraki returns to discuss how testosterone testing should inform treatment decisions, what benefits to expect, and the questions surrounding fertility and long-term safety. Timestamps: [03:50] Dr Austin Baraki's work [06:33] When and why test? [10:36] Probability and context impacts interpretation [14:13] What labs measure [21:15] Specific vs nonspecific symptoms [28:35] Primary vs secondary hypogonadism [32:30] Lifestyle vs TRT decisions [35:21] TRT risks [39:32] Testing timing and variability [41:55] Androgen receptor genetics [44:28] Free vs total testosterone [48:57] Low-normal results: what now? [57:45] TRT risks?: heart and prostate [01:03:55] Side effects and monitoring Links: Go to episode page & resources Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Instagram: @austin_barbellmedicine Barbell Medicine McCormack & Holmes, 2020 – Your results may vary: the imprecision of medical measurements #417: Austin Baraki, MD – What Do Nutrient Blood Tests Actually Tell Us?: Understanding Biomarkers #334: Austin Baraki, MD – Potential Harms of Screening, Overdiagnosis and Overtreatment | 1h 08m 19s | ||||||
| 10/6/26 | #622: Body Composition Testing: Methods & Interpretation – Prof. Grant Tinsley | Body composition testing is widely used in research, sport and clinical practice. But what are these methods actually measuring, and how much confidence should we place in the numbers they produce? In this episode, we examine the assumptions behind common approaches including DXA, bioelectrical impedance, and skinfold measurements. We discuss the distinction between accuracy and reliability, the value and limitations of repeated measurements, and how coaches, clinicians, researchers and individuals can select an appropriate method and interpret the data without overstating its precision. Joining Danny to discuss these issues is Professor Grant Tinsley, Professor of Human Performance at Texas Tech University and Director of its Energy Balance and Body Composition Laboratory. Timestamps: [03:04] Grant Tinsley's research [05:25] What body composition means [08:50] Skeletal muscle mass vs. fat-free mass vs. lean soft tissue [11:51] How different methods estimate body composition [23:38] Group vs individual accuracy [31:09] Standardizing testing conditions and assessments [36:36] Reliability testing thresholds [40:08] Understanding phase angle in bioelectrical impedence results [45:02] Consumer devices [50:55] Not all benefit from monitoring [54:14] Using data wisely [01:02:55] Key Ideas (premium-only) Links/Resources: Go to episode page (references, bio, study notes) Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course | 1h 04m 02s | ||||||
| 9/22/26 | #621: Hedonic Overeating, Food Wanting and Impact of Perception – Prof. Graham Finlayson | Why do some foods feel difficult to stop eating, while others can be highly enjoyable without prompting the same tendency to overconsume? Answering this requires a clearer understanding of food reward, including the distinction between liking a food, wanting it, and perceiving it as easy to overeat. In this episode, we examine how nutritional composition, sensory characteristics, learned beliefs and the eating context may shape hedonic overeating. It also considers the limits of using broad food categories to explain complex eating behaviour. Discussing all this is Professor Graham Finlayson, professor of Psychobiology at the University of Leeds, whose research focuses on human appetite, food reward and the psychological processes involved in eating behaviour and weight control. Timestamps [04:02] Prof. Finlayson's research [06:06] Food reward [07:13] Liking versus wanting [12:43] Measuring wanting in research [15:27] Does wanting predict overeating? [16:36] Study on hedonic overeating [23:19] Perception and context effects [26:24] Does ultra processing classification add anything? [36:09] Key takeaways and future work [40:35] Premium key ideas Links/Resources: Go to episode page Subscribe to Sigma Nutrition Premium Join the Sigma newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course Study: Finlayson et al., 2025 – Food-level predictors of self-reported liking and hedonic overeating: Putting ultra-processed foods in context | 42m 39s | ||||||
| 9/15/26 | #620: BPC-157 and Peptide Medications: What Do We Know? – Jordan Feigenbaum, MD | Commonly people are talking about "peptides" to refer to a heterogeneous group of peptide medications or investigational compounds. These are increasingly promoted for injury recovery, tissue repair, performance and longevity, with BPC-157 attracting particular attention. But what evidence supports the claims made about these compounds? How should animal studies, biological mechanisms and personal anecdotes be interpreted? What is currently known about their safety? And what do recent regulatory discussions actually mean for their medical status and availability? In this episode, physician and Barbell Medicine founder Dr. Jordan Feigenbaum examines the evidence surrounding BPC-157 and other peptide medications, alongside the wider questions of risk, access and informed decision-making. Timestamps [00:13] What we want to address [04:47] Interview start [05:29] What do we mean by "peptides"? [10:32] BPC-157 evidence [16:49] Sourcing of peptides [20:19] The gray zone of pro-peptide communication [24:16] Risk sourcing vs drug effects [26:25] FDA lists and compounding [31:05] Risk tolerance and informed consent [43:02] Why did pharma abandon peptide research? [47:44] Harm reduction debate [51:48] Practical takeaways [56:20] Key Ideas segment (Premium members only) Episode Resources Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Barbell Medicine Instagram: jordan_barbellmedicine Book: Signal: What Testosterone Levels Are Telling You About Your Health Related episode: #524: Strength & Fitness Levels for Reducing Chronic Disease Risk & Promoting Health Ageing – Jordan Feigenbaum, MD Further reading: Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. 2025. Ruenzi M, Stolte M, Veljaca M, et al. Efficacy and safety of PL 14736 (BPC 157) in patients with active ulcerative colitis. Gastroenterology. 2005. Meeting abstract; full study not published. | 57m 32s | ||||||
| 9/8/26 | #619: How Much Fish Should a Healthy Diet Contain? | Most dietary guidelines recommend eating one to two servings of fish per week, often specifying that at least one serving should be oily fish. But how directly is that recommendation supported by evidence? And does adding fish to the diet improve outcomes? This episode examines where current fish-intake recommendations originated, why findings may appear contradictory, and what substitution analyses can tell us about replacing fish with alternative options. It also considers evidence from pescatarian and vegetarian cohorts, including whether adding fish would improve an already high-quality diet and whether removing it from a plant-forward diet is likely to provide further benefit. Timestamps [00:20] Setting out the question at hand [03:26] Overview of typical fish intake recommendations [07:10] Is there good evidence for suggested intakes? [08:10] Historical context [13:22] Key evidence: DART trial and cohort data [19:27] Analysis from Mohan et al. [25:04] Comparator issue: what is fish replacing? [30:52] Fish protein vs. plant protein [44:29] Vegetarian vs. pescatarian cohorts [55:20] Conclusions [01:00:50] Key Ideas segment (Premium-only) Episode Resources Go to episode page (with full study reference list) Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Subscribe to Alan's Alinea Nutrition Education Hub Enroll in the next cohort of our Applied Nutrition Literacy course | 1h 03m 22s | ||||||
| 9/1/26 | #618: How Wellness & Optimisation Culture Can Commodify Science – Nick Tiller, PhD | Wellness and optimisation culture increasingly presents itself as "science-based". But citing studies, using technical language, or having scientific credentials does not guarantee that the underlying evidence is being represented accurately. In this episode, exercise science researcher Dr. Nick Tiller, discusses how science can be selectively packaged, overstated, and used to support commercially attractive health claims. It explores the difference between science communication and science commodification, why scientific scepticism is distinct from cynicism, how anecdotes and mechanistic explanations can mislead, and why a single peer-reviewed study should never be treated as definitive evidence. The conversation also looks further upstream at problems within science itself, including low statistical power, p-hacking, publication bias, questionable research practices, and academic incentives that may favour novelty and positive findings. These issues can then be amplified through media, social platforms, and the wellness industry until tentative findings become confident recommendations. Timestamps: [03:14] Interview start [06:22] The health and wellness "lie" [08:38] Optimization and the illusion of control [11:14] Science communicators vs commodifiers [14:21] Vitamin D hype case study [20:54] Spotting misinformation online [24:50] Skepticism not cynicism [28:47] Guidelines for debunking [33:46] Spotting the grift pattern [41:25] Bad science in academia [54:47] Key ideas segment (Premium-only) Episode Resources: Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Tiller's website Tiller & Phillips, 2023 – How Skepticism (not Cynicism) Can Raise Scientific Standards and Reform the Health and Wellness Industry Tiller et al., 2024 – The Nontechnical Summary: A New Initiative to Enhance the Translation of Sports Science Research and Reduce the Spread of Misinformation | 56m 55s | ||||||
| 8/25/26 | #617: What Does Effective Athlete Support Look Like in Practice? – Gemma McGuinness | Effective athlete support requires more than delivering technically correct nutrition advice. It depends on understanding the athlete's wider environment, anticipating the pressures that disrupt good intentions, and building flexible routines that remain useful across training, competition, travel and everyday life. This episode explores how practitioners can move beyond rigid prescriptions, use "good, better, best" options, measure meaningful progress, and create environments in which athletes can communicate openly about difficulties. It also examines identity, transitions out of sport, and why sustainable support should develop an athlete's autonomy rather than dependence on the practitioner. To discuss all this is Gemma McGuinness, registered performance nutritionist, former professional footballer and co-founder of Verus Performance. Timestamps: [02:38] Interview start [03:48] Nutrition beyond performance [10:10] Identity and food choices [18:47] Standards versus perfectionism [24:52] Planning that actually works [28:32] Measuring progress in athletes [33:37] Where discipline can cause problems [38:40] Building high performance environments [45:37] Key ideas (Premium-only) Links: Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Instagram: @gemmcguinnness Verus Performance Davey Nutrition Gemma's Substack | 46m 40s | ||||||
| 8/18/26 | Fiber: Independent Benefits or Just a Proxy for Healthy Foods? | This episode answers one of the questions raised in the most recent Q&A episode on Sigma Nutrition Premium. The full episode includes the following questions: Fiber: Independent effect or proxy for healthy foods? Exposure frequency for matched dose of red meat MTHFR gene mutations and 5-MTHF Typical fish oil supplements vs pharmaceutical-grade products Health impacts of saturated fat in coconut products Do I need to consume whole grains? Could the increasing use of AI pose a threat to doing rigorous science? To listen to the entire episode (plus the back catalogue of all Premium-exclusive episodes) become a member of Sigma Nutrition Premium. For episode info and mentioned research go to the episode page here. | 21m 00s | ||||||
| 8/11/26 | #616: More Testing, Better Health? Harms of Overdiagnosis & Overtreatment - Austin Baraki, MD | Medical screening is often framed as an uncomplicated good: if disease is found earlier, treatment can begin earlier and outcomes should improve. This episode examines why that reasoning is incomplete. Screening can produce benefit, but it can also generate false positives, incidental findings, overdiagnosis, overtreatment and diagnostic cascades. Dr. Austin Baraki discusses the distinction between screening people without relevant symptoms and investigating a clinical problem, the probabilistic interpretation of test results, biases that can make screening appear more effective than it is, and the importance of shared decision-making before a test is ordered. Timestamps: [03:35] What screening means [06:36] Choosing what to screen [11:59] Sensitivity and specificity [16:54] Predictive value and prevalence [22:16] Harms of screening and testing [31:02] Overdiagnosis and biases [41:40] The $50,000 physical [44:49] Overdiagnosis vs false positives [53:03] Overtreatment and surveillance [57:22] Clinician action bias [01:02:30] What to screen for Links: Go to episode page (with resources) Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Instagram: @austin_barbellmedicine Twitter: @AustinBaraki | 1h 15m 28s | ||||||
| 8/4/26 | #615: Why Processing Doesn't Determine the Healthfulness of Plant-Based Diets – Alysha Thompson, PhD | What does the evidence actually show when we look at plant-based dietary patterns through the lens of food processing? And does classifying foods as "ultra-processed" meaningfully change how we interpret the relationship between plant-based diets and long-term health outcomes? A recent large prospective cohort analysis examined both healthful and unhealthful plant-based dietary patterns, and importantly, stratified the contributing foods based on whether they were classified as ultra-processed or non-ultra-processed. In this episode, the study's lead author Dr Alysha Thompson, discusses the many intesresting aspects to the analysis. These include how the dietary indices were constructed, the challenges of applying NOVA classification to self-reported dietary data, the role of residual confounding in observational nutrition research, and the extent to which we can or cannot infer independent effects of processing from these findings. We also consider the broader implications for the use of processing-based classifications in nutrition science and whether this adds meaningful explanatory value beyond traditional assessments of diet quality. Timestamps [03:02] Interview start [05:08] The key research question [07:52] Study design [17:25] Building diet scores [21:11] NOVA classification challenges [25:04] Key findings [38:30] NOVA debate and stance [43:44] Adjustments and mediators [48:11] Future research directions [54:37] Key ideas (premium-only) Resources: Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Paper: Plant-Based Diets, Ultra-Processed Foods, and Risks of Mortality and Major Chronic Diseases: A Prospective Cohort Study | 56m 18s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 7/21/26 | nutrition coachinghuman skills+5 | Krista Scott-Dixon | Sigma Nutrition1% Better Academy+2 | USCanada+2 | nutrition coachinghuman skills+6 | — | 56m 30s | ||
| 7/14/26 | supplement safetymedication interactions+4 | Giulia Guerrini | ExamineGPhC | — | supplement safetymedication interactions+4 | — | 57m 18s | ||
| 7/7/26 | #612: Does Sweet Taste Exposure Actually Develop Preference? – Prof. Katherine Appleton | A common idea is that repeated exposure to sweet taste strengthens our preference for sweetness, which then drives greater intake of sweet foods and drinks. This idea is often used in arguments about fruit, low-calorie sweeteners, diet drinks, and the supposed need to "reset" taste preferences by avoiding sweetness altogether. But does the evidence actually support that causal chain? In this episode, Prof. Katherine Appleton, Professor of Psychology at Bournemouth University, discusses what is known about sweet taste exposure, sweet preference, and how these concepts are measured in the scientific literature. Timestamps: [04:23] Interview starts [07:35] Sweetness terms explained [10:17] Sweet liker phenotypes [14:03] Liking vs wanting vs preference [19:18] Trial evidence overview [23:48] Policy and practical impact [30:41] Why we eat foods Links: Go to episode page (incl. links to studies) Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course | 38m 59s | ||||||
| 6/30/26 | electrolytessports nutrition+4 | Zoë RomKylee Van Horn | Sigma Nutrition | — | electrolyteshydration+7 | — | 55m 08s | ||
| 6/23/26 | blood glucose responsesclinical thresholds+5 | — | Sigma Nutrition | — | blood glucoseclinical thresholds+5 | — | 13m 26s | ||
| 6/16/26 | food substitution modelshealth impact of foods+3 | — | — | — | food substitutionhealth impact+5 | — | 57m 04s | ||
| 6/9/26 | red meatcancer risk+4 | Alan | Sigma Nutrition Radio | — | unprocessed red meatcancer risk+5 | — | 1h 09m 44s | ||
| 6/2/26 | performance nutritionelite sport+4 | James Morehen | elite rugbyfootball+1 | — | nutritionelite rugby+5 | — | 1h 08m 02s | ||
| 5/26/26 | gut healthmicrobiome testing+4 | Emily Leeming, PhDEmily Leeming | — | — | gut healthmicrobiome+4 | — | 50m 41s | ||
| 5/21/26 | PCOSnutrition+5 | — | Sigma NutritionPMOS (PCOS) and Diet: What Can Nutrition Realistically Do? | — | PMOSPCOS+8 | — | 19m 13s | ||
| 5/19/26 | fat lossnutrition strategies+4 | Luke Hanna | University College LondonUniversity of Portsmouth | — | body compositionfat loss+7 | — | 41m 23s | ||
| 5/12/26 | fastingnutrient timing+3 | Prof. James Betts | — | — | fastingnutrient timing+5 | — | 56m 13s | ||
| 5/5/26 | nutrition researchscientific rigor+4 | David Allison, PhD | — | — | nutritionscientific inquiry+5 | — | 52m 16s | ||
| 4/28/26 | dietary fiberessential nutrients+3 | Andrew Reynolds | — | — | dietary fiberessential nutrient+5 | — | 59m 14s | ||
| 4/21/26 | Avoidant/Restrictive Food Intake Disordereating disorders+4 | Megan HellnerKatherine Hill | Sigma Nutrition RadioDSM-5 | — | ARFIDeating disorders+5 | — | 50m 27s | ||
| 4/14/26 | gallstonesgallbladder conditions+3 | Angela Madden | University of Hertfordshire | — | gallstonesdiet+5 | — | 53m 26s | ||
| 4/7/26 | metabolismplant-based diets+5 | — | Sigma NutritionA Plant Based Diet Reverses Heart Disease: True or False?+2 | — | metabolic problemscardiovascular disease+7 | — | 22m 09s | ||
| 3/31/26 | scientific reasoningnutrition controversies+3 | Alan | Sigma Nutrition Radio | — | finite knowledgeinfinite ignorance+5 | — | 2h 00m 12s | ||
| 3/24/26 | unprocessed red meattype 2 diabetes+4 | Gil CarvalhoMario Kratz | Sigma Nutrition Radio | — | red meatdiabetes risk+4 | — | 1h 18m 33s | ||
| 3/17/26 | glycaemic controlexercise and nutrition+4 | Jenna Gillen | University of Toronto | — | glycaemic controlexercise+5 | — | 44m 24s | ||
| 3/10/26 | behavioral psychologydiet counselling+4 | David Creel, PhD, RD | Cleveland Clinic | — | behavior changenutrition+5 | — | 51m 43s | ||
| 3/3/26 | omega-3 fatty acidsclinical trials+4 | — | CochraneHu et al.+4 | — | omega-3EPA+5 | — | 1h 06m 11s | ||
| 2/24/26 | neuroplasticitycognitive impairment+4 | Dr. Majid Fotuhi | Johns Hopkins Mind/Brain InstituteHarvard Medical School+2 | — | neuroplasticitycognitive decline+6 | — | 38m 21s | ||
Showing 33 of 641
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for Sigma Nutrition Radio
Peaked at #2 in IL, top 10 in 2 of 46 tracked markets, currently #2 in IL.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| IL | — | #2 | #2 | — |
| South Africa | — | #6 | #6 | — |
| Norway | — | #14 | #14 | — |
| Ireland | — | #17 | #17 | — |
| PE | — | #18 | #18 | — |
| TW | — | #20 | #20 | — |
| TR | — | #21 | #21 | — |
| New Zealand | — | #22 | #22 | — |
| BE | — | #23 | #23 | — |
| RO | — | #23 | #23 | — |
| Netherlands | — | #24 | #24 | — |
| United Kingdom | — | #26 | #26 | — |
| ID | — | #29 | #29 | — |
| SA | — | #31 | #31 | — |
| HU | — | #33 | #33 | — |
| IL | — | #33 | #33 | — |
| Finland | — | #38 | #38 | — |
| CZ | — | #40 | #40 | — |
| India | — | #41 | #41 | — |
| VN | — | #42 | #42 | — |
Chart Positions
46 placements across 44 markets.
Chart Positions
46 placements across 44 markets.